Natixis Advisors LLC Acquires 8,669 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Natixis Advisors LLC grew its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 20.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 51,343 shares of the company’s stock after acquiring an additional 8,669 shares during the quarter. Natixis Advisors LLC’s holdings in Stevanato Group were worth $1,027,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Tri Locum Partners LP acquired a new position in shares of Stevanato Group during the second quarter worth about $10,370,000. Thrivent Financial for Lutherans acquired a new position in Stevanato Group during the 2nd quarter worth approximately $30,477,000. Thornburg Investment Management Inc. grew its stake in shares of Stevanato Group by 279.1% during the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after acquiring an additional 549,378 shares in the last quarter. Comgest Global Investors S.A.S. grew its stake in shares of Stevanato Group by 56.8% during the 2nd quarter. Comgest Global Investors S.A.S. now owns 394,120 shares of the company’s stock worth $7,228,000 after acquiring an additional 142,754 shares in the last quarter. Finally, Raymond James Trust N.A. raised its holdings in shares of Stevanato Group by 18.7% in the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after purchasing an additional 1,613 shares during the last quarter.

Stevanato Group Stock Up 0.6 %

Shares of NYSE STVN opened at €20.04 ($21.09) on Wednesday. Stevanato Group S.p.A. has a one year low of €16.56 ($17.43) and a one year high of €34.73 ($36.56). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The stock’s fifty day moving average price is €19.45 and its two-hundred day moving average price is €19.64.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. The company’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.16 earnings per share. On average, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Citigroup decreased their price objective on Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a report on Wednesday, August 7th.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.